Skip to content
Home » Blog » DiaUnion’s Samia Hamdan presented at the Immunology of Diabetes Society annual congres

DiaUnion’s Samia Hamdan presented at the Immunology of Diabetes Society annual congres

At IDS2024 today, Samia Hamdan presented how DiaUnion now uses ADAP (Antibody Detection by Agglutination-PCR) multiplex assays as the first line of screening.

This means that screening for all three diseases in DiaUnion 2.0, type 1 diabetes, celiac disease and autoimmune thyroiditis, is performed in a single laboratory process, saving time, cost and human resources.

By combining multiplex assays with laboratory automation, such as a pipette robot, in DiaUnion 2.0, analyzes that previously took a week to complete can now be performed in one day.